Skip to main navigation Skip to search Skip to main content

Study Results from Korea University College of Medicine in the Area of Breast Cancer Reported (Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer)

Press/Media

Period2025.11.3

Media coverage

1

Media coverage

  • TitleStudy Results from Korea University College of Medicine in the Area of Breast Cancer Reported (Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date25.11.3
    PersonsYoung Min Kim
View all 1
View less